# US 8,771,957 B2 · Sequencing using a predetermined coverage amount of polynucleotide fragments

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,771,957 B2
- Document ID: US8771957B2
- Status: Granted
- Kind: B2
- Application number: 13/975,215
- Filed: 2013-08-23
- Published: 2013-12-26
- Granted: 2014-07-08
- Earliest claimed: 2005-06-15
- Assignees: Callida Genomics, Inc.
- Applicants: Callida Genomics, Inc.
- Inventors: Radoje Drmanac
- Web page: https://patentgrep.com/patent/US8771957B2

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C07H 21/04: with deoxyribosyl as saccharide radical
- C07K 1/047: {Simultaneous synthesis of different peptide species; Peptide libraries}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/682: Signal amplification
- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/6869: Methods for sequencing
- G01N 15/1404: Handling flow, e.g. hydrodynamic focusing
- G01N 15/1434: Optical arrangements
- C12Q 2525/151: repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
- C12Q 2525/313: Branched oligonucleotides
- C12Q 2531/125: Rolling circle
- C12Q 2565/513: characterised by the pattern of the arrayed oligonucleotides
- Y10S 977/778: within specified host or matrix material, e.g. nanocomposite films
- Y10S 977/789: in array format
- Y10S 977/792: Nucleic acid array, e.g. human genome array
- Y10S 977/88: with arrangement, process, or apparatus for testing
- Y10S 977/882: Assembling of separate components, e.g. by attaching
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The invention provides methods and kits for ordering sequence information derived from one or more target polynucleotides. In one aspect, one or more tiers or levels of fragmentation and aliquoting are generated, after which sequence information is obtained from fragments in a final level or tier. Each fragment in such final tier is from a particular aliquot, which, in turn, is from a particular aliquot of a prior tier, and so on. For every fragment of an aliquot in the final tier, the aliquots from which it was derived at every prior tier is known, or can be discerned. Thus, identical sequences from overlapping fragments from different aliquots can be distinguished and grouped as being derived from the same or different fragments from prior tiers. When the fragments in the final tier are sequenced, overlapping sequence regions of fragments in different aliquots are used to register the fragments so that non-overlapping regions are ordered. In one aspect, this process is carried out in a hierarchical fashion until the one or more target polynucleotides are characterized, e.g. by their nucleic acid sequences, or by an ordering of sequence segments, or by an ordering of single nucleotide polymorphisms (SNPs), or the like.

## Claims

### Claim 1

A method of sequencing one or more target polynucleotides, the method comprising the steps of:
providing a predetermined coverage amount of fragments of the one or more target polynucleotides to form a population containing overlapping first-sized fragments of the one or more target polynucleotides;
forming a number of separate mixtures from the population of first-sized fragments;
fragmenting the first-sized fragments in the separate mixtures to form populations of second-sized fragments;
incorporating oligonucleotide tags into the second-sized fragments in the separate mixtures to produce tagged second-sized fragments,
whereby an oligonucleotide tag incorporated into a second-sized fragment in a separate mixture identifies that mixture;
obtaining sequence reads by sequencing at least a portion of a plurality of the tagged second-sized fragments from at least some of the mixtures; and
obtaining complete or partial nucleotide sequences of the one or more target polynucleotides by assembling at least a portion of the sequence reads, wherein the assembling comprises determining that second-sized fragment sequences comprising the same oligonucleotide tag have the same mixture of origin.

### Claim 2 (depends on 1)

The method of claim 1, wherein the step of forming mixtures includes replicating the first-sized fragments in the separate mixtures.

### Claim 3 (depends on 1)

The method of claim 1, wherein the step of obtaining sequence reads comprises:
generating concatemers that comprise multiple copies of tagged second-sized fragments that substantially cover the first-sized fragments in at least some of the separate mixtures;
forming a random array of the concatemers fixed to a surface at a density such that at least a majority of the concatemers are optically resolvable; and
generating a number of sequence reads from the concatemers,
wherein the number of sequence reads is selected such that the reads substantially cover the first-sized fragments.

### Claim 4 (depends on 3)

The method of claim 3, wherein the step of generating the number of sequence reads comprises:
(a) contacting the concatemers with a first set of probes under conditions that permit the formation of perfectly matched duplexes between probes of the first set of probes and complementary sequences on the concatemers;
(b) contacting the concatemers with a second set of probes under conditions that permit the formation of perfectly matched duplexes between probes of the second set of probes and complementary sequences on the concatemers;
(c) producing ligated probes by ligating together pairs of probes hybridized to a concatemer at contiguous sites, wherein the pairs comprise a first probe from the first set of probes and a second probe from the second set of probes;
(d) identifying the sequences of the ligated probes; and
(e) repeating steps (a) through (d) until the sequences of the first-sized fragments is substantially determined from the identities of the sequences of the ligated probes.

### Claim 5 (depends on 1)

The method of claim 1, comprising combining the separate mixtures to form one or more combined mixtures, and obtaining sequence reads from tagged second-sized fragments or from subfragments of the tagged second-sized fragments of the target polynucleotide(s) in the combined mixtures.

### Claim 6 (depends on 1)

The method of claim 1, comprising determining a haplotype of an organism.

### Claim 7 (depends on 1)

The method of claim 1, comprising determining a genetic variation associated with a disease.

### Claim 8 (depends on 1)

The method of claim 1, wherein the target polynucleotide is genomic DNA and the first-sized fragments are generated by sonication, treatment with DNase I, or tagged PCR amplification of said genomic DNA.

### Claim 9 (depends on 1)

The method of claim 1, wherein the number of separate mixtures is selected so that the probability of overlapping first-sized fragments in any one of the mixtures is less than 10%.

### Claim 10 (depends on 1)

The method of claim 1, wherein the number of separate mixtures is selected so that the probability of overlapping first-sized fragments in any one of the mixtures is less than 1%.

### Claim 11 (depends on 1)

The method of claim 1, wherein the number of separate mixtures is selected so that the probability of overlapping first-sized fragments in any one of the mixtures is less than 0.01%.

### Claim 12 (depends on 1)

The method of claim 1, wherein the steps of fragmenting the first-sized fragments and incorporating the oligonucleotide tags are accomplished by amplifying the first-sized fragments or subfragments thereof by tagged PCR amplification so as to produce the tagged second-sized fragments.

### Claim 13

A method of determining a nucleotide sequence of one or more target polynucleotides of an organism without cell-based cloning, the method comprising the steps of:
providing a plurality of aliquots of a sample, at least some of which comprise a plurality of first-sized fragments of the target polynucleotide(s);
producing tagged second-sized fragments from the first-sized fragments;
mixing together fragments from a plurality of the aliquots to form a mixture;
obtaining sequence reads from second-sized fragments of the mixture; and
assembling the sequence reads to produce an assembled sequence of the target polynucleotide(s) by a process that comprises grouping sequence reads from fragments that have the same tag.

### Claim 14 (depends on 13)

The method of claim 13, wherein least ninety percent of the aliquots containing a plurality of first-sized fragments contain only non-overlapping fragments.

### Claim 15 (depends on 13)

The method of claim 13, comprising determining a haplotype of an organism.

### Claim 16 (depends on 13)

The method of claim 13, wherein the step of providing a plurality of aliquots of a sample comprises obtaining a nucleic acid-containing biological sample from an animal and dividing the sample into a plurality of aliquots.

### Claim 17 (depends on 16)

The method of claim 16, wherein the nucleic acid is genomic DNA of the animal.

### Claim 18 (depends on 17)

The method of claim 17, wherein the animal is a human.

### Claim 19

A method of determining a nucleotide sequence of one or more target polynucleotides of an organism without cell-based cloning, the method comprising the steps of:
providing a plurality of aliquots, at least some of which comprise a plurality of first-sized fragments of the target polynucleotide(s) wherein any given portion of the target polynucleotide(s) is represented by a single non-overlapping fragment in sixty percent or more of the mixtures containing such portion;
producing tagged second-sized fragments from the first-sized fragments;
mixing together second-sized fragments from a plurality of the aliquots to form a mixture;
obtaining sequence reads from second-sized fragments of the mixture; and
assembling the sequence reads to produce an assembled sequence of the target polynucleotide(s) by a process that comprises grouping sequence reads from fragments that have the same tag.